2019/2020
Annual report
MAY 12, 2021
CELLINK DIGITAL CAPITAL MARKETS DAY
Follow our financial story as we change the future of medicine.
On this page you can find financial reports, news and other information on CELLINK. Subscribe to our page to get all the latest updates.
Employees
600
+
Net sales
416
MSEK
Increased revenue of
167
%
Latest press releasesMore
April 30, 2021RegulatoryCELLINK announces an increase in number of shares and votes
April 26, 2021RegulatoryBulletin from Annual General Meeting in CELLINK AB (publ)
April 6, 2021CELLINK and UPM Biomedicals has formed a collaboration for ground-breaking 3D bioprinting developments
March 31, 2021Invitation to CELLINKs digital Capital Markets Day on May 12, 2021 with focus on the bioconvergence agenda
March 31, 2021RegulatoryCELLINK announces an increase in number of shares and votes
March 26, 2021RegulatoryNotice of Annual General Meeting of CELLINK AB (publ)
March 22, 2021CELLINK completes the acquisition of MatTek Corporation
March 17, 2021RegulatoryCELLINK publishes Annual Report 2019/2020
March 15, 2021CELLINK launches the BIO MDX Series , a scaled-up revolution in biomedical manufacturing
March 12, 2021RegulatoryCELLINK AB announces the completion of the offering of Senior Unsecured Convertible Bonds convertible into Class B shares and a Class B share issue in an overall amount of SEK 3.0 billion
March 11, 2021RegulatoryCellink AB announces an offering of Senior Unsecured Convertible Bonds convertible into Class B shares and a Class B share issue in an expected amount of SEK 2.75 billion
March 10, 2021Correction in CELLINK’s Swedish press release
March 10, 2021RegulatoryCELLINK has entered into an agreement to acquire MatTek, the global leader in in-vitro technology and alternative drug testing models
March 1, 2021CELLINK completes the acquisition of Ginolis Oy
February 25, 2021RegulatoryYear-end report 19/20: Continued strong organic growth, positive result and strategic investments for the future
February 19, 2021Invitation to CELLINK’s earnings call – Year-end Report 2019/2020
February 15, 2021RegulatoryCELLINK has entered into an agreement to acquire the advanced robotics and diagnostics automation company Ginolis
February 8, 2021CELLINK announce distribution agreement including new products for Single-Cell RNA Sequencing and NGS Library Preparation
January 28, 2021CELLINK announces third year extension of collaboration with a global biopharmaceutical company for drug discovery
January 25, 2021CELLINK launches UP.SIGHT, a rapid, all-in-one imager and single-cell dispenser that offers double assurance of clonality
December 17, 2020RegulatoryBulletin from the extraordinary general meeting in CELLINK AB (publ)
December 4, 2020CELLINK and Atelerix team up to enable the shipping at room temperature of fragile 3D bioprinted constructs by the world’s bioprinting community
November 27, 2020CELLINK welcomes new scientific advisor Professor Robert Langer from MIT and co-founder of Moderna
November 25, 2020RegulatoryNotice of extraordinary general meeting of CELLINK AB (publ)
November 9, 2020CELLINK will help develop 3D bioprinted personalised scaffolds for tissue regeneration of ankle joint s as part of the TRIANKLE project
October 22, 2020RegulatoryQ4 19/20: Strong organic growth and important strategic acquisition under continued challenging conditions
October 21, 2020CELLINK launches C.WASH, an innovative liquid handling system for automated media change in micro-well plates
October 20, 2020Conference call interim report
October 20, 2020RegulatoryNomination Committee for CELLINK AB in preparation for the 2021 Annual General Meeting
October 2, 2020RegulatoryBoard Member Artur Aira is taking the position as Bioprinting Business Area Manager
September 30, 2020RegulatoryCELLINK announces an increase in number of shares and votes
September 18, 2020RegulatoryCELLINK publishes prospectus and new financial information due to admission to trading of shares of series B on Nasdaq Stockholm
September 11, 2020RegulatoryBulletin from the extraordinary general meeting in CELLINK AB (publ)
September 7, 2020CELLINK have been granted funding totalling €3,910,000 from the EU as a part of the Horizon 2020 program. CELLINK’s portion of the grant is €270,000
September 2, 2020CELLINK completes the acquisition of Scienion AG
August 31, 2020RegulatoryCELLINK announces an increase in number of shares and votes
August 28, 2020CELLINK welcomes new scientific advisor Professor Ido Amit from the Weizmann Institute of Science
August 27, 2020Cytena and AstraZeneca collaborate to develop plate based microbioreactors for cell line development workflows
August 20, 2020RegulatoryNotice of extraordinary general meeting of CELLINK AB (publ)
August 19, 2020RegulatoryCELLINK has completed directed share issues of SEK 946 million to finance the acquisition of SCIENION AG and create further room for a continued M&A agenda
August 19, 2020RegulatoryCELLINK announces intention to carry out directed share issues of approximately 13.5% of the outstanding shares to finance the acquisition of SCIENION AG
August 19, 2020RegulatoryCELLINK has entered into an agreement to acquire precision dispensing company Scienion Ag
August 13, 2020CELLINK announces strategic partnership with Carcinotech to advance 3D-bioprinting technology for cancer research
July 16, 2020RegulatoryBulletin from the extraordinary general meeting in CELLINK AB (publ)
July 14, 2020CELLINK and Kugelmeiers Ltd. announce strategic partnership for 3D printing cell spheroids
July 9, 2020RegulatoryQ3 19/20: Continued growth and Main market listing during an ongoing pandemic
Calendar More
May 12, 2021Q1 report 2021
May 12, 2021Digital capital markets day
August 18, 2021Q2 report 2021
November 10, 2021Q3 report 2021